SurgoCap Partners LP Mala Gaonkar
New York, NY 11 processed 13Fs on this site, 2023 Q4 to 2026 Q2
- $3.1B
- 13 holdings
- 2026 Q2
- +3.3% QoQ
- Top 5 57.9%
AUM over time
Book
| MCK, McKesson | Add +26.3% | 608,317 | $494.42 | $301M | +126,675 | +$19M | |
| GEV, GE Vernova | Reduce −4.6% | 1,176,703 | $254.98 | $300M | −56,631 | +$89M | |
| LPLA, LPL Financial | Add +42.8% | 780,721 | $232.63 | $182M | +233,880 | +$29M | |
| META, Meta Platforms | New | 303,844 | $572.44 | $174M | +303,844 | +$174M | |
| AAPL, Apple | Add +49.1% | 711,707 | $233.00 | $166M | +234,529 | +$65M | |
| GEHC, GE HealthCare | Add +48.5% | 1,708,189 | $93.85 | $160M | +557,736 | +$71M | |
| SNPS, Synopsys | Add +42.8% | 282,106 | $506.39 | $143M | +84,504 | +$25M | |
| GWRE, Guidewire Software | Reduce −15.1% | 687,286 | $182.94 | $126M | −122,179 | +$14M | |
| BX, Blackstone | Reduce −22.5% | 800,544 | $153.13 | $123M | −232,116 | −$5.3M | |
| CRS, Carpenter Technology | New | 662,712 | $159.58 | $106M | +662,712 | +$106M | |
| NU, Nu Holdings | Reduce −7.6% | 7,004,177 | $13.65 | $96M | −576,087 | −$2.1M |
Exits / last held
Gone since 2024 Q2, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| QCOM, Qualcomm | Exit | 0 | $199.18 | $124M | −624,110 | −$124M | |
| NVDA, Nvidia | Exit | 0 | $123.54 | $106M | −857,606 | −$106M | |
| CNM, Core & Main | Exit | 0 | $48.94 | $102M | −2,075,233 | −$102M | |
| MSFT, Microsoft | Exit | 0 | $446.95 | $87M | −195,434 | −$87M |
Filings history
11 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 13 | $3.1B | +3.3% | 13F-HR | 8/13/2026 | 000091957426005191 |
| 2026 Q1 | 14 | $3B | −17.1% | 13F-HR | 5/15/2026 | 000091957426003167 |
| 2025 Q4 | 17 | $3.6B | +0.4% | 13F-HR | 2/17/2026 | 000091957426001016 |
| 2025 Q3 | 16 | $3.6B | +35.8% | 13F-HR | 11/13/2025 | 000091957425006748 |
| 2025 Q2 | 13 | $2.6B | +30.8% | 13F-HR | 8/14/2025 | 000091957425004655 |
| 2025 Q1 | 12 | $2B | +4.3% | 13F-HR | 5/15/2025 | 000091957425003084 |
| 2024 Q4 | 12 | $1.9B | −3.1% | 13F-HR | 2/14/2025 | 000091957425001210 |
| 2024 Q3 | 12 | $2B | +17.1% | 13F-HR | 11/14/2024 | 000091957424006446 |
| 2024 Q2 | 13 | $1.7B | −8.2% | 13F-HR | 8/14/2024 | 000091957424004550 |
| 2024 Q1 | 14 | $1.9B | +30.1% | 13F-HR | 5/15/2024 | 000091957424003006 |
| 2023 Q4 | 15 | $1.4B | — | 13F-HR | 2/14/2024 | 000091957424001147 |
About
SurgoCap Partners LP
11 processed 13Fs on this site, 2023 Q4 to 2026 Q2